The phenotypic spectrum of MYH3‐associated disease was recently broadened to include vertebral fusions, which are a defining clinical feature of spondylocarpotarsal synostosis syndrome. This evidence concerns the gene MYH3 and spondylocarpotarsal synostosis syndrome.